Strategic Partnership Leverage the 2020 joint venture with SG Blocks to position Clarity Diagnostics as a preferred supplier for CLIA-certified laboratory setups. Target organizations expanding in in-house lab capabilities and turnkey lab solutions that can be integrated with Clarity’s rapid diagnostic tests and equipment.

Diversified Product Line Capitalize on Clarity’s broad portfolio across Urinalysis, Infectious Disease, Fertility, Cancer Markers, Drugs of Abuse, Hemoglobin, and Glucose Testing to cross-sell to hospitals, clinics, and OTC distributors. Map customers with multiple needs to bundle solutions and drive higher average order value.

SMB and Growth Focus With a lean team and revenue in the low millions, target mid-market labs, ambulatory care networks, and regional health systems looking for cost-efficient rapid diagnostics. Propose scalable solutions and implementation support to reduce total cost of ownership.

Support and Training Highlight Clarity’s robust customer service and technical support from Boca Raton for pre- and post-sales, training, and troubleshooting. Develop enablement programs for distributors and in-house staff to shorten ramp-up and accelerate order cycles.

Market Positioning Position Clarity as a cost-effective, compliant alternative within the rapidly growing rapid diagnostics market. Emphasize regulatory compliance, revenue generation through new technology adoption, and demonstrated savings versus name brands to win procurement decisions.